MD Blog: The Cochrane Review Conclusion for Hepatitis C DAA Therapies is Wrong

The Cochrane Review Conclusion for Hepatitis C DAA Therapies is Wrong by Paul Y. Kwo, MD, FACG; Mitchell L. Shiffman, MD, FACG; and David E. Bernstein, MD, FACG There are few diseases that cause such morbidity and mortality as chronic hepatitis ...

Study Suggests Alternative to Common HCV Treatment with Equally High SVR, No PPI Modification Needed

  Mitchell L. Shiffman, MD, FACG Poster 413 Efficacy of Ombitasvir/Paritaprevir/ and Dasabuvir +/-Ribavirin in Patients Receiving Concomitant Acid-Reducing Agents in Phase 3 Trials Author Insight from Mitchell L Shiffman, MD, FACG, Director, ...